FR2336130A1 - Composes utilisables dans le traitement des infections bacteriennes - Google Patents
Composes utilisables dans le traitement des infections bacteriennesInfo
- Publication number
- FR2336130A1 FR2336130A1 FR7609025A FR7609025A FR2336130A1 FR 2336130 A1 FR2336130 A1 FR 2336130A1 FR 7609025 A FR7609025 A FR 7609025A FR 7609025 A FR7609025 A FR 7609025A FR 2336130 A1 FR2336130 A1 FR 2336130A1
- Authority
- FR
- France
- Prior art keywords
- clavulanic
- urinary tract
- infections
- respiratory
- illness
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000000844 anti-bacterial effect Effects 0.000 title abstract 3
- 229940088710 antibiotic agent Drugs 0.000 title abstract 3
- 208000019206 urinary tract infection Diseases 0.000 title abstract 3
- 239000002253 acid Substances 0.000 title abstract 2
- 208000015181 infectious disease Diseases 0.000 title abstract 2
- 230000003387 muscular Effects 0.000 title abstract 2
- 230000000241 respiratory effect Effects 0.000 title abstract 2
- 150000007513 acids Chemical class 0.000 title 1
- 229930182555 Penicillin Natural products 0.000 abstract 2
- 229930186147 Cephalosporin Natural products 0.000 abstract 1
- 241000588724 Escherichia coli Species 0.000 abstract 1
- 208000005141 Otitis Diseases 0.000 abstract 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 abstract 1
- 241000588769 Proteus <enterobacteria> Species 0.000 abstract 1
- 206010057190 Respiratory tract infections Diseases 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 229940124587 cephalosporin Drugs 0.000 abstract 1
- 150000001780 cephalosporins Chemical class 0.000 abstract 1
- 208000019258 ear infection Diseases 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 208000004396 mastitis Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229940049954 penicillin Drugs 0.000 abstract 1
- 150000002960 penicillins Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 210000001635 urinary tract Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D503/02—Preparation
- C07D503/06—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Cephalosporin Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB15209/75A GB1545467A (en) | 1975-04-14 | 1975-04-14 | Deoxyclavulanic acid and deoxyisoclavulanic acid and derivatives thereof |
| GB3967175 | 1975-09-27 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2336130A1 true FR2336130A1 (fr) | 1977-07-22 |
| FR2336130B1 FR2336130B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1979-06-22 |
Family
ID=26251136
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7609025A Granted FR2336130A1 (fr) | 1975-04-14 | 1976-03-29 | Composes utilisables dans le traitement des infections bacteriennes |
Country Status (22)
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2364216A1 (fr) * | 1976-09-09 | 1978-04-07 | Glaxo Lab Ltd | Derives de la clavuline et leur procede de preparation |
| WO1991015208A1 (en) * | 1990-03-30 | 1991-10-17 | Beecham Group Plc | Veterinary treatment |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT363181B (de) * | 1976-10-25 | 1981-07-10 | Glaxo Lab Ltd | Verfahren zur herstellung von neuen clavulansaeurederivaten |
-
1976
- 1976-03-12 PT PT64897A patent/PT64897B/pt unknown
- 1976-03-12 GR GR50291A patent/GR58256B/el unknown
- 1976-03-18 YU YU00694/76A patent/YU69476A/xx unknown
- 1976-03-24 AT AT215576A patent/AT342199B/de not_active IP Right Cessation
- 1976-03-24 IL IL49279A patent/IL49279A/xx unknown
- 1976-03-25 IE IE628/76A patent/IE42666B1/en unknown
- 1976-03-29 ES ES446468A patent/ES446468A1/es not_active Expired
- 1976-03-29 FR FR7609025A patent/FR2336130A1/fr active Granted
- 1976-03-31 DK DK156576A patent/DK144066C/da not_active IP Right Cessation
- 1976-03-31 AR AR262754A patent/AR208773A1/es active
- 1976-04-05 MX MX000141U patent/MX3453E/es unknown
- 1976-04-07 FI FI760946A patent/FI760946A7/fi not_active Application Discontinuation
- 1976-04-09 NO NO761241A patent/NO761241L/no unknown
- 1976-04-12 LU LU74749A patent/LU74749A1/xx unknown
- 1976-04-12 SE SE7604287A patent/SE427037B/xx unknown
- 1976-04-12 NL NL7603840A patent/NL7603840A/xx not_active Application Discontinuation
- 1976-04-13 CA CA250,165A patent/CA1074802A/en not_active Expired
- 1976-04-13 CH CH470276A patent/CH602742A5/xx not_active IP Right Cessation
- 1976-04-13 JP JP51042313A patent/JPS51127093A/ja active Pending
- 1976-04-13 DE DE19762616088 patent/DE2616088A1/de not_active Withdrawn
- 1976-04-14 HU HU76BE1258A patent/HU175444B/hu unknown
- 1976-04-14 AU AU13020/76A patent/AU497577B2/en not_active Expired
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2364216A1 (fr) * | 1976-09-09 | 1978-04-07 | Glaxo Lab Ltd | Derives de la clavuline et leur procede de preparation |
| WO1991015208A1 (en) * | 1990-03-30 | 1991-10-17 | Beecham Group Plc | Veterinary treatment |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Esposito et al. | Topical and oral treatment of chronic otitis media with ciprofloxacin: a preliminary study | |
| BR9406979A (pt) | Composto,composicão farmaceutica para tratar uma doenca inflamatória suscetivel de tratamento com um agente anti- inflamatório nao esteroidal processos para tratar uma doenca inflamatória e para preparar um composto sal famacéuticamente aceitável uso de um composto composicão farmaceutica anti-inflamatória nao esteroidal | |
| EA200100623A1 (ru) | Кетолидные антибиотики | |
| ES8500931A1 (es) | Procedimiento para la obtencion de acidos quinoloncarboxilicos | |
| FR2336130A1 (fr) | Composes utilisables dans le traitement des infections bacteriennes | |
| DE1770062B2 (de) | Tetrahydroisochinolylpenicilline, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen | |
| EA200001029A1 (ru) | Производные гигромицина | |
| Ungar et al. | Investigation of the antibacterial and toxic action of certain acridine derivatives | |
| DE2963010D1 (en) | 3-chloro-6-hydroxy-5-methylbenzoic acid derivatives, corresponding pharmaceutical preparations, growth promoting compositions, the use of the compounds for promoting growth in certain animals and their manufacture | |
| FR2342292A1 (fr) | Antibiotiques, inhibiteurs de b-lactamases, clavulamiques et leur procede de preparation | |
| ES480905A1 (es) | Un procedimiento para la preparacion de un tiol acido y sus sales y esteres. | |
| US3026247A (en) | Pharmaceutical preparation | |
| GB1392241A (en) | Antibacterial agents and a process for the preparation thereof | |
| FR2335208A1 (fr) | Nouveaux derives de la spermine a activite bacteriostatique, procede pour leur fabrication et compose pharmaceutique les contenant | |
| Henning et al. | Cefadroxil single-dose long and short therapy versus amoxicillin in female urinary tract infections | |
| ES445176A1 (es) | Un procedimiento para la produccion de acido 6-(d-2-(3-hi- droxipiridazin-4-carbonamido)-2-(p-hidroxifenil) acetamido) penicilanico. | |
| FR2372630A1 (fr) | Agents antibacteriens du type de la cephalosporine | |
| Kaplan et al. | Clinical evaluation of furadantin, a new urinary antiseptic | |
| IT1036078B (it) | Composizione antibatterica per anima i | |
| CN118948866A (zh) | 葡萄糖酸铜联用米诺环素在制备皮肤细菌感染外用药物中的医药用途 | |
| ES8403135A1 (es) | Un procedimiento para la preparacion de acido 6,-metoxi-6, -2-2-metilfenoxicarbonil-2-(tien-3-il) acetamido penicilanico. | |
| FR2007387A1 (en) | P-hydroxyphenylhydrazones antibacterial | |
| FR2007385A1 (en) | Substd p-hydroxyphenylhydrazones antibacterial | |
| FR2007384A1 (en) | P-hydroxyphenylhydrazones antibacterial | |
| Nakasawa et al. | Clinical Studies of Pipemidic Acid in the Field of Pediatrics |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |